Cell Free Protein Expression Market Stand Out As The Biggest Contributor In Healthcare With Major Key Players Promega Corporation, CellFree Sciences, Biotechrabbit GmbH, Bioneer Corporation, Cube Biotech GmbH

The Global Cell Free Protein Expression Market, by Product Type (Expression Systems (Prokaryotic Expression Systems, Mammalian Cell Expression Systems, Insect Cell Expression Systems, Yeast Cell Expression Systems, Other Systems) and Consumables and Other Products), by Application (Therapeutic Application and Research Application) By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes and Contract Research Organizations) was valued US$ 177.1 million in 2017, and is projected to exhibit a CAGR of 6.2% over the forecast period (2018 - 2026) as highlighted in a new report published by Coherent Market Insights.

Cell free protein expression is vital step for study or research in proteomics, as protein can only be extracted if the cell free protein expression process is conducted through cell lysate. Thus, it enables researchers to rapidly express and manufacture small amounts of functional proteins within short duration, as this process does not require cell culture, gene transfection, or extensive protein purification, which in turn is fueling growth of the cell free protein expression market.

Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/1082

Growth of cell free expression systems is mainly driven by increasing novel approaches to the development of robust, rapid, and cost effective protein expression technique. Moreover, acquisitions is enabling market consolidation. For instance, in July 2017, Sanofi Pasteur acquired Protein Science Company to strengthen its recombinant-based influenza vaccine portfolio. Protein Science’s insect cell-based baculovirus expression vector system (BEVS) is a protein expression technology to develop recombinant protein vaccines. According to Sanofi, BEVS is rapid and cost effective system than other production system. This acquisition is expected to broaden Sanofi’s flu portfolio and technological strength.

Small scale vendors have the opportunity to enter into the cell free protein expression market. The reagents and kits used for cell free protein expression include enzymes, beads, and detergents. Hence, the local market players can enter the cell free protein expression market with the same or innovative products at cost effective price.

Increasing collaboration among government and market players is also expected to propel the cell free protein expression market growth during the forecast period. For instance, in September, 2015, African Academy of Sciences (AAS) and the New Partnership for Africa’s Development (NEPAD) Agency received US$ 5.5 million as initial seed funding from the Bill & Melinda Gates Foundation, the Wellcome Trust. The UK Department for International Development launched Alliance for Accelerating Excellence in Africa (AESA). Furthermore, in 2016, Thermofisher scientific, Inc. partnered with Hamilton Bonaduz AG, to accelerate automation platform’s access to forensic customers. The automation platform includes AutoLys STAR 4x4 for sample lysis and DNA purification, which is the only hand-free automation solution for lysis and DNA extraction.

Get HOLISTIC Request Sample Copy Of This Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/1082

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.